Mindray Medical listed on the NYSE in September 2006. In December 2013, it was attacked by short-seller Ottoman Bay Research alleging that profits were being faked and then parked in large short-term investments and cash. This was followed by a second short-seller report, this time from J Capital, three months later, in February 2014, with similar allegations. The reports failed to prompt any director or auditor resignations and, as such, remain unproven. The company was taken private in 2015 and then relisted on the Chinese mainland in 2018.

Last updated May 2023

The information on this page has been compiled from publicly available sources. GMT Research Limited has not verified the information and does not warrant its accuracy. Any claims made or views expressed are not necessarily those of GMT Research Limited.